Literature DB >> 33707182

Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots.

Jacqui Wise1.   

Abstract

Entities:  

Year:  2021        PMID： 33707182     DOI： 10.1136/bmj.n699

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  95 in total

1.  Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study.

Authors:  Xintong Li; Anna Ostropolets; Rupa Makadia; Azza Shoaibi; Gowtham Rao; Anthony G Sena; Eugenia Martinez-Hernandez; Antonella Delmestri; Katia Verhamme; Peter R Rijnbeek; Talita Duarte-Salles; Marc A Suchard; Patrick B Ryan; George Hripcsak; Daniel Prieto-Alhambra
Journal:  BMJ       Date:  2021-06-14

Review 2.  Review of COVID-19 viral vector-based vaccines and COVID-19 variants.

Authors:  Rachana Vanaparthy; Gisha Mohan; Deepa Vasireddy; Paavani Atluri
Journal:  Infez Med       Date:  2021-09-10

Review 3.  Flavonoids are promising safe therapy against COVID-19.

Authors:  Moza Mohamed Alzaabi; Rania Hamdy; Naglaa S Ashmawy; Alshaimaa M Hamoda; Fatemah Alkhayat; Neda Naser Khademi; Sara Mahmoud Abo Al Joud; Ali A El-Keblawy; Sameh S M Soliman
Journal:  Phytochem Rev       Date:  2021-05-22       Impact factor: 7.741

4.  The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination.

Authors:  Alfonso Ciccone; Bruno Zanotti
Journal:  Eur J Intern Med       Date:  2021-05-10       Impact factor: 7.749

Review 5.  An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times.

Authors:  Cielo García-Montero; Oscar Fraile-Martínez; Coral Bravo; Diego Torres-Carranza; Lara Sanchez-Trujillo; Ana M Gómez-Lahoz; Luis G Guijarro; Natalio García-Honduvilla; Angel Asúnsolo; Julia Bujan; Jorge Monserrat; Encarnación Serrano; Melchor Álvarez-Mon; Juan A De León-Luis; Miguel A Álvarez-Mon; Miguel A Ortega
Journal:  Vaccines (Basel)       Date:  2021-04-27

6.  Willing or Hesitant? A Socioeconomic Study on the Potential Acceptance of COVID-19 Vaccine in Japan.

Authors:  Yoshihiko Kadoya; Somtip Watanapongvanich; Pattaphol Yuktadatta; Pongpat Putthinun; Stella T Lartey; Mostafa Saidur Rahim Khan
Journal:  Int J Environ Res Public Health       Date:  2021-05-02       Impact factor: 3.390

7.  Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine.

Authors:  Leonor Dias; Ricardo Soares-Dos-Reis; João Meira; Diana Ferrão; Pedro Ribeirinho Soares; Ana Pastor; Guilherme Gama; Luísa Fonseca; Vítor Fagundes; Marta Carvalho
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-05-25       Impact factor: 2.136

Review 8.  Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

Authors:  Ali Pormohammad; Mohammad Zarei; Saied Ghorbani; Mehdi Mohammadi; Mohammad Hossein Razizadeh; Diana L Turner; Raymond J Turner
Journal:  Vaccines (Basel)       Date:  2021-05-06

Review 9.  Antiphospholipid antibodies and risk of post-COVID-19 vaccination thrombophilia: The straw that breaks the camel's back?

Authors:  Rossella Talotta; Erle S Robertson
Journal:  Cytokine Growth Factor Rev       Date:  2021-05-28       Impact factor: 7.638

10.  A Quantitative Benefit-Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy.

Authors:  Raffaele Palladino; Daniele Ceriotti; Damiano De Ambrosi; Marta De Vito; Marco Farsoni; Giuseppina Seminara; Francesco Barone-Adesi
Journal:  Vaccines (Basel)       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.